By
University of Montana
Published: Oct. 23, 2023, 7:35 p.m.·
Tags:
Vaccines,
Research and development
MISSOULA, 23 October 2023 – The National Institutes of Health recently awarded a $12.3 million contract to the University of Montana to develop a novel vaccine adjuvant for use in a tuberculosis vaccine. Adjuvants are substances that boost the effectiveness of vaccines.
Read More →